Geography and Race/Ethnicity Impact Access to Pediatric Cancer Care
New research has revealed disparities in access to cancer care among children, adolescents, and young adults in the United States.
Diagnosis & Disease Information
Blood Type May Predict Risk of Venous Thromboembolism Among Patients With Cancer
Researchers sought to determine whether ABO blood type may impact the risk of developing VTE in patients with cancer.
FDA Greenlights Ibuprofen Oral Suspension Compounding to Help With Hospital Supply
Increased demand for ibuprofen oral suspension products due to a surge in 3 circulating viruses prompted the Agency to issue compounding guidance.
Intervention Reduces Use of Systemic Therapy at End of Life in Cancer Patients
An intervention can increase serious illness conversations and reduce the use of systemic therapy at the end of life in patients with cancer.
Age, Smoking Are Most Important Risk Factors for Any Cancer
Absolute risk for developing any cancer within five years 2 percent or greater for nearly all those aged 50 years or older.
Most Pediatric Oncologists Don’t Discuss Prognosis When Diagnosing Patients, Study Suggests
Pediatric oncologists often choose not to provide prognostic information when discussing a new cancer diagnosis, a new study suggests.
COVID-19-Related Treatment Delays, Discontinuations May Increase Disparities in Cancer Care
Race and ethnicity are associated with delays or discontinuations of cancer treatment after COVID-19, but social determinants of health are not, a study suggests.
What Do We Know About Cancer Risk in Patients With Anemia?
Patients with anemia may know some of the risks associated with the condition, but do they know about potential cancer-related risks? How can health care professionals educate patients on the risks, and what is known about the potential association between newly diagnosed anemia and cancer risk?
Low-Dose Melphalan Achieves Survival Outcomes, Relapse Rates Similar to Standard Dose
Researchers compared outcomes for patients with multiple myeloma who received conditioning regimen of melphalan at a lower dose with outcomes using the standard dose.
Oncologists May Lack Understanding of Biosimilars but Use Them Anyway, Survey Suggests
US medical oncologists may lack understanding of biosimilars and have limited access to education about these products, a survey suggests.
- Loading...
Loading...
Next post in General Hematology
Loading... 
Loading...